Oracle’s Pivotal Earnings Report: A Test of AI Ambitions and Financial Fortitude

Enterprise software leader Oracle faces a critical market test. On December 8, the company will release its fiscal 2026 second-quarter results, following a punishing 26% share price decline throughout November. The upcoming report is seen as a crucial indicator that will either validate the firm’s aggressive growth strategy or amplify existing concerns over its debt and partnerships.

The Bull Case: Untapped AI Potential and Massive Backlog

Despite recent volatility, several prominent analysts maintain strongly positive outlooks. Deutsche Bank analyst Brad Zelnick recently reaffirmed his buy rating, setting a price target of $375. This represents a potential doubling from recent levels. Zelnick’s core argument centers on a significant market underestimation of Oracle’s artificial intelligence infrastructure business.

He presented a scenario using conservative assumptions: even if Oracle secured no additional AI revenue after fiscal 2026 and was still responsible for 50% of contracted lease payments, he projects earnings per share could reach $12 by 2030, with free cash flow hitting $12 billion. This framework, he suggests, substantially limits the stock’s downside risk.

Adding to the bullish sentiment, HSBC holds a $382 price target. The bank highlights Oracle’s enormous contractual backlog, with remaining performance obligations (RPO) now exceeding $500 billion. This figure is viewed as evidence of a robust, pre-committed revenue pipeline.

The Bear Case: Debt, Partnership Risks, and Execution Questions

Not all market observers share this optimism. DA Davidson adopted a more cautious stance in late November, reducing its price target from $300 to $200 while maintaining a neutral rating. Analyst Gil Luria has raised questions about the quality of recent large contracts, particularly those linked to AI research organization OpenAI.

Should investors sell immediately? Or is it worth buying Oracle?

Morgan Stanley’s credit analysts have voiced sharper concerns. Analyst Lindsay Tyler recently highlighted potential counterparty risk associated with OpenAI, the rapid expansion of Oracle’s balance sheet, and a perceived lack of clarity regarding funding strategy. A central question remains: Can OpenAI fulfill its announced commitment to over $300 billion in computing capacity over a five-year period?

Compounding these worries is Oracle’s swiftly growing debt load. With a debt-to-equity ratio of 3.33 and an $18 billion bank loan specifically for constructing a data center in New Mexico, investors are questioning the sustainability of this aggressive expansion.

December 8: The Key Metrics and Commentary

All eyes will be on the post-market release on December 8. Consensus estimates point to revenue of $16.2 billion and earnings per share between $1.27 and $1.31. However, commentary from CEO Safra Catz and founder Larry Ellison during the subsequent conference call may carry even greater weight. Market participants will seek clarity on several fronts:

• The Stargate Project: Updates on the progress of building out dedicated AI data center capacity.
• Financing Strategy: How the company plans to fund its substantial capital expenditures.
• The OpenAI Partnership: Any new information regarding the status and scale of the multi-hundred-billion-dollar agreement.
• Cloud Guidance: Whether management reaffirms its forecast for $18 billion in cloud infrastructure revenue, which would represent 77% growth.

The previous quarter already delivered a surprise, with remaining performance obligations soaring 359% to $455 billion, driven largely by the OpenAI deal and other sizable contracts.

A Defining Moment for Shareholders

Oracle shares are caught between two powerful narratives. On one side is the compelling growth story tied to AI and cloud infrastructure dominance. On the other are mounting anxieties over leverage, counterparty risk, and the realism of its ambitious targets. The upcoming quarterly report is widely expected to set the directional tone for the stock in the months ahead.